{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03865875",
            "orgStudyIdInfo": {
                "id": "18-635"
            },
            "organization": {
                "fullName": "Massachusetts General Hospital",
                "class": "OTHER"
            },
            "briefTitle": "Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program",
            "officialTitle": "Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "pilot-study-of-a-multimodal-prehabilitation-pancreatic-cancer-program"
        },
        "statusModule": {
            "statusVerifiedDate": "2021-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-08-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-03-05",
            "studyFirstSubmitQcDate": "2019-03-05",
            "studyFirstPostDateStruct": {
                "date": "2019-03-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2021-05-13",
            "lastUpdatePostDateStruct": {
                "date": "2021-05-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Motaz Qadan",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Massachusetts General Hospital"
            },
            "leadSponsor": {
                "name": "Massachusetts General Hospital",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research is to explore the benefits of an exercise and nutrition program during total neoadjuvant therapy (TNT) in preparation for surgery for participants that have pancreatic ductal adenocarcinoma (PDAC)",
            "detailedDescription": "This research study involves an exercise and nutrition program that will consist of twice weekly exercise sessions and discussion with a nutritionist with possible nutrition supplementation.\n\nThe names of the study interventions involved in this study are:\n\n* Exercise Intervention\n* Nutrition Intervention\n\nThe research study procedures include: screening for eligibility, study evaluations, and follow up visits."
        },
        "conditionsModule": {
            "conditions": [
                "Pancreatic Ductal Adenocarcinoma"
            ],
            "keywords": [
                "Pancreatic Ductal Adenocarcinoma",
                "Total Neoadjuvant Therapy",
                "Prehabilitation",
                "Exercise",
                "Nutrition",
                "Optimization",
                "Surgery"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Multimodal Prehabilitation Program",
                    "type": "EXPERIMENTAL",
                    "description": "Pretreatment exercise program and nutrition program\n\n-The prehabilitation intervention will include the following components: (1) a standardized fitness program and (2) nutritional counseling and optimization. Patients are enrolled in the program within 8 weeks of being diagnosed and continued until operation",
                    "interventionNames": [
                        "Behavioral: Exercise Program",
                        "Behavioral: Nutrition Program"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Exercise Program",
                    "description": "Participants will start the exercise program within 2 weeks of enrollment and will continue until surgery. This program will consist of twice weekly individualized sessions with a trainer.",
                    "armGroupLabels": [
                        "Multimodal Prehabilitation Program"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Nutrition Program",
                    "description": "Each patient enrolled will undergo nutritional assessment at their initial post-enrollment visit to develop an individualized nutrition plan to be implemented up until when the patient undergoes surgery.",
                    "armGroupLabels": [
                        "Multimodal Prehabilitation Program"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants to complete prehabilitation program",
                    "description": "At least 50% (95% confidence interval +/- 16%) of participants will complete 50% of the components of the prehabilitation program.",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria\n\n* Adults age 18 years or older.\n* Diagnosed within 8 weeks with upfront resectable, borderline resectable, or locally advanced unresectable PDAC as defined by the National Comprehensive Cancer Network (NCCN).\n* Planning to undergo TNT at MGH.\n* Planning to receive modified FOLFIRINOX for neoadjuvant chemotherapy.\n* Planning to undergo surgical resection of PDAC at MGH.\n* Verbal fluency in English.\n\nExclusion Criteria\n\n* Metastatic disease.\n* Previous treatment for pancreas adenocarcinoma and no prior therapy for any cancer within 5 years.\n* Known history of cognitive or psychologic impairment.\n* Known history of physical impairment such as immobility, use of walking aids, or required wheelchair use.\n* Known history of the following orthopedic comorbidities: advanced osteoarthritis or rheumatoid arthritis, mobility-limiting amputations, orthopedic injuries, or widespread chronic pain (e.g. fibromyalgia).\n* Known history of the following pulmonary comorbidities: severe chronic obstructive pulmonary disease (COPD) defined as FEV1 \u2264 50%, emphysema, interstitial lung disease, and/or use of supplemental oxygen.\n* Known history of the following cardiovascular comorbidities: uncontrolled hypertension, severe congestive heart failure (NYHA Class IV), and/or myocardial infarction within the last 6 months.\n* Inability to tolerate diet through routine oral routes and/or patients with strict nutritional restrictions, allergies, and/or dietary preferences.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Naomi Sell, MD, MHS",
                    "role": "CONTACT",
                    "phone": "650-868-9440",
                    "email": "nsell@partners.org"
                },
                {
                    "name": "Motaz Qadan, MD, PhD",
                    "role": "CONTACT",
                    "phone": "617-643-5153",
                    "email": "mqadan@mgh.harvard.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Motaz Qadan, MD, PhD",
                    "affiliation": "Massachusetts General Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Motaz Qadan, MD, PhD",
                            "role": "CONTACT",
                            "phone": "617-643-5153",
                            "email": "mqadan@mgh.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: \\[contact information for Sponsor Investigator or designee\\]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF"
            ],
            "timeFrame": "Data can be shared no earlier than 1 year following the date of publication",
            "accessCriteria": "MGH - Contact the Partners Innovations team at http://www.partners.org/innovation",
            "url": "http://www.dfhcc.harvard.edu/crs-resources/ODQ_Documents/02_CT.GOV_CTRP/Guidance_on_Data_Sharing.pdf"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13110",
                    "name": "Pancreatic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "T4387",
                    "name": "Pancreatic Cancer",
                    "asFound": "Pancreatic Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}